Total item
Cart Subtotal
$0.00 Biological Activity
CB 300919 is a potential therapy for ovarian cancer. Preclinical data showed that this quinazoline-based compound CB 300919 has a continuous exposure (96 h) growth inhibition IC50 value of 2 nM in human CH1 ovarian tumor xenograft
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 17.12 mL | 85.6 mL | 171.2 mL |
| 0.5 mM | 3.42 mL | 17.12 mL | 34.24 mL |
| 1 mM | 1.71 mL | 8.56 mL | 17.12 mL |
| 5 mM | 0.34 mL | 1.71 mL | 3.42 mL |
*The above data is based on the productmolecular weight 584.11. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Catalog Num | A11359 |
|---|---|
| M. Wt | 584.11 |
| Formula | C32H34ClN7O2 |
| Solubility | DMSO |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 289715-28-2 |
| Synonyms | CB300919, CB-300919 |
| SMILES | CN1CCN(CC1)CC2=NC3=CC(=C(C=C3C(=O)N2C)CN(CC#C)C4=CC=C(C=C4)C(=O)NCC5=CN=CC=C5)Cl |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy CB 300919 | CB 300919 Supplier | purchase | cost | manufacturer | order | distributor | buy 289715-28-2| 289715-28-2 Supplier | purchase 289715-28-2 | 289715-28-2 cost | 289715-28-2 manufacturer | order 289715-28-2 | 289715-28-2 distributor
Adooq Quality Guarantee
We promise all products perform as described.